期刊文献+

N-酰基-1-苄基四氢异喹啉衍生物的合成和GABA转运蛋白抑制作用 被引量:2

Synthesis and GABA transporter inhibitory activities of N-acyl-1-benzyl tetrahydroisoquinoline derivatives
下载PDF
导出
摘要 目的设计合成N-酰基-1-(3,4-二甲氧基)苄基-6,7-二甲氧基-1,2,3,4-四氢异喹啉类化合物,评价其抑制GABA转运蛋白对GABA的摄取作用。方法经核磁共振氢谱、质谱、高分辨质谱和红外光谱确证目标物的结构,并经体外GAT-1竞争抑制性结合试验进行活性筛选。结果与结论合成了4个目标化合物,初步活性试验表明,化合物1c和1d对GAT-1的抑制作用要大于阳性对照药(R)-3-哌啶甲酸,显示较强的GAT-1抑制作用。 Aim To design and synthesize a series of new N-acyl-l-benzyl tetrahydroisoquinoline derivatives and evaluate their GABA transporter inhibitory activities in vitro. Method Four new compounds were synthesized and their structures were confirmed by ^1H-NMR, MS, HRMS and IR. The IC50 values of the synthetic compounds 1a- 1d in vitro test for[3H]-GABA uptake inhibitors were determined using cultured cell lines expressing mouse GAT-1. Results and conclusion All the target compounds show definite GABA transporter inhibitory activities in vitro. Some of them, such as compounds lc and ld have more potent GABA transporter inhibitory activities than(R )-nipecotic acid.
出处 《中国药物化学杂志》 CAS CSCD 2005年第6期336-339,共4页 Chinese Journal of Medicinal Chemistry
基金 上海市科委重大攻关项目(03DZ19201)
关键词 药物化学 化合物制备 化学合成 1-苄基四氢异喹啉类化合物 GABA转运蛋白抑制活性 medicinal chemistry compound preparation chemical synthesis 1-benzyl tetrahydroisoquinolinederivatives GABA transporter inhibitory activity
  • 相关文献

参考文献9

  • 1Patricia V, Zoya K, Emilia M, et al. GABA signalling during development: new data and old questions [ J ].Cell Tissue Res, 2001,305(2) :239 - 246.
  • 2Basile AS. Direct and indirect enhancement of GABA ergic neurotransmission by ammonia: implications for the pathogenesis of hyperamrnonemic syndromes[J].Neurochem Int, 2002, 41(2 - 3) : 115 - 122.
  • 3Lewis DA, Volk DW, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction [ J ]. Psychopharmacology, 2004, 174(1) :143 - 150.
  • 4Eiden Lee E. The vesicular neurotransmitter transporters: current perspectives and future prospects [J].The Faseb J, 2000, 14(15):2396-2400.
  • 5Schousboe A, Sarup A, Larsson OM, et al. GABA transporters as drug targets for modulation of GABAergic activity [ J ]. Biochem Pharmacol, 2004, 68(8) : 1557 - 1563.
  • 6Ho B, Crider AM, Stables JP. Synthesis and structure-activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acids and related pharmacophores[J]. Eur J Med Chem, 2001, 36 (3):265 -286.
  • 7Soha Y, Shin Mill, Lee JS, et al. Oxidative DNA damage and glioma cell death induced by tetrahydropapaveroline[J]. Murat Res, 2003, 544 (1): 129 -142.
  • 8Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease[J]. Neurosci Res, 1997, 29(1) : 99-111.
  • 9Wert KL, Chackalamannil S, Miller E, et al. Hofmann degradation of fl-hydroxy ammonium salts, α-and β-hydroxylaudanosine, 7-hydroxyglaucine, and 13-hydroxyxylopinine[J ]. J Org Chem, 1982, 47 ( 26 ) : 5141-5150.

同被引文献16

  • 1谭成侠,翁建全,孙娜波,沈德隆.2-二乙胺基-6-甲基-4-羟基嘧啶的合成[J].农药,2005,44(6):261-262. 被引量:7
  • 2孙继铨,潘毅,陈华.四氢罂粟碱的合成工艺改进[J].精细化工中间体,2007,37(3):49-50. 被引量:5
  • 3吴军,林学圃,金磊.2-二甲氨基-5,6-二甲基-4-羟基嘧啶的合成研究[J].农药,1997,36(1):14-15. 被引量:6
  • 4Davis F, Mohanty P. Asymmetric synthesis of the protoberberine alkaloid (S)-(-)-xylopinine using enantiopure sulfinimines[ J]. J Org Chem,2002,67(4) : 1290 - 1296.
  • 5Naskanishi H. Pharmacological studies of xylopinine, 2,3,10,11 -tetrametboxy-5,6-13,13a-tetrahydro-8-dibenzo (a-g) quinolizine, semisynthesized from phellodendrine isolated from phellodendron amurense rupr [ J ]. Jap J Pharmacol, 1962,12:208 - 222.
  • 6Chea A, Hout S, Tabatabze N, et al. Antimalarial activity of alkaoids isolated from Stephania rotunda [ J ]. J Ethnopharmacol, 2007,112 : 132 - 137.
  • 7Ginny Dai-Ho, Mariano P. Novel photochemical-diradical cyelization methods for protoberberine alkaloid synthesis preparation of ( ± )-xylopinine and ( ± )-stylopine [ J ]. J Org Chem,1987,52(4) :704 -706.
  • 8Augusto J, Rodrigues R, Rudolph A, et al. Diastereoselective synthesis of cularine alkaloids via enium ions and an easy entry to isoquinolines by aza-witting electrocyclic ringclosure [ J ]. J Org Chem ,2004,69 ( 9 ) :2920 - 2928.
  • 9Weisbach J, Kirkpatrick J, Macko E, et al. Synthesis and pharmacology of some α-oxy- and α-hydmxy-1- benzyhetrahydroisquinolines[J]. J Med Chem, 1968, 11 : 752 - 760.
  • 10Dayalan A, Visweawaran V. Synthesis, characterization and antimicrobial activity studies of 1- & 2-[ { 2-( 3, 4- dimethoxyphenyl) ethyl } -methylamino ] sulphonyl naphthalenes [J]. Asian J Chem,2008,20(2) :1411 -1419.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部